CCL2 and cancer: Analysis of the database previously analyzed by Cangelosi et al. demonstrated elevated CCL2 RNA expression in patients that were deceased, compared to those still alive (Fig. 1A), as well as in patients with progressive disease defined as progression, relapse, or cancer-specific death (Fig. 1B).